Antisense oligodeoxynucleotides against thrombomodulin suppress the cell growth of lung adenocarcinoma cell line A549

Pathology International

Volumn 52, Issue 3, 2002, Pages 204-213

  Fujiwara, Masakazu ^a   Jin, Enjing ^a   Ghazizadeh, Mohammad ^a   Kawanami, Oichi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

A549 cells; Antisense oligodeoxynucleotides; Cell growth; Lung adenocarcinoma; Thrombomodulin

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; IDOXURIDINE; THROMBOMODULIN;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL COUNT; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; PRIORITY JOURNAL;

ADENOCARCINOMA; CELL CYCLE; CELL DIVISION; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; THROMBOMODULIN; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0036964701     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.2002.01332.x     Document Type: Article

References (42)

1. Esmon NL, Owen WG, Esmon CT. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C.J. Biol. Chem.1982;257: 859-864.
2. Suzuki K, Kusumoto H, Deyashiki Y et al. Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation. EMBO J. 1987;6: 1891-1897.
3. Jackman RW, Beeler DL, Fritze L, Soff G, Rosenberg RD. Human thrombomodulin gene is intron depleted: nucleic acid sequences of the cDNA and gene predict protein structure and suggest sites of regulatory control. Proc. Natl Acad. Sci. USA 1987;84: 6425-6429.
4. Fuentes-Prior P, Iwanaga Y, Huber R et al. Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex.Nature 2000;404: 518-525.
5. Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J. Biol. Chem. 1989; 264: 4743-4746.
6. Walker FJ. Regulation of activated protein C by a new protein. A possible function for bovine protein S. J. Biol. Chem. 1980; 255: 5521-5524.
7. Fulcher CA, Gardiner JE, Griffin JH, Zimmerman TS. Pro-teolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor V.Blood 1984;63: 486-489.
8. Suzuki K, Nishioka J, Hayashi T, Kosaka Y. Functionally active thrombomodulin is present in human platelets. J. Biochem. (Tokyo) 1988;104: 628-632.
9. Ogura M, Ito T, Maruyama I et al. Localization and biosynthesis of functional thrombomodulin in human megakaryocytes and a human megakaryoblastic cell line (MEG-01). Thromb. Haemost. 1990;64: 297-301.
10. McCachren SS, Diggs J, Weinberg JB, Dittman WA. Thrombo-modulin expression by human blood monocytes and by human synovial tissue lining macrophages. Blood 1991; 78: 3128-3132.
11. Pindon A, Hantai D, Jandrot-Perrus M, Festoff BW. Novel expression and localization of active thrombomodulin on the surface of mouse brain astrocytes.Glia 1997;19: 259-268.
12. Raife TJ, Lager DJ, Madison KC et al. Thrombomodulin expression by human keratinocytes. Induction of cofactor activity during epidermal differentiation.J. Clin. Invest. 1994;93: 1846-1851.
13. Buck CA, Edelman JM, Buck CE, Kennedy G, Baldwin HS. Expression patterns of adhesion receptors in the developing mouse lung: functional implications. Cell Adhes. Commun. 1996;4: 69-87.
14. Collins CL, Ordonez NG, Schaefer R et al. Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma.Am. J. Pathol. 1992;141: 827-833.
15. Yonezawa S, Maruyama I, Sakae K, Igata A, Majerus PW, Sato E. Thrombomodulin as a marker for vascular tumors. Comparative study with factor VIII and Ulex europaeus I lectin.Am. J. Clin. Pathol. 1987;88: 405-411.
16. Tezuka Y, Yonezawa S, Maruyama I et al. Expression of throm-bomodulin in esophageal squamous cell carcinoma and its relationship to lymph node metastasis.Cancer Res. 1995;55: 4196-4200.
17. Ogawa H, Yonezawa S, Maruyama I et al. Expression of throm-bomodulin in squamous cell carcinoma of the lung: its relationship to lymph node metastasis and prognosis of the patients. Cancer Lett. 2000;149: 95-103.
18. Tamura A, Komatsu H, Hebisawa A, Kurashima A, Mori M, Katayama T. Is thrombomodulin useful as a tumor marker of a lung cancer?Lung Cancer 1996;15: 189-195.
19. Skailes GE, Menasce L, Banerjee SS, Shanks JH, Logue JP. Adenocarcinoma of the rete testis.Clin. Oncol. 1998;10: 401-403.
20. Healy AM, Rayburn HB, Rosenberg RD, Weiler H. Absence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system.Proc. Natl Acad. Sci. USA 1995;92: 850-854.
21. Zhang Y, Weiler-Guettler H, Chen J et al. Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity.J. Clin. Invest. 1998;101: 1301-1309.
22. Ordonez NG. Value of thrombomodulin immunostaining in the diagnosis of mesothelioma. Histopathology 1997; 31: 25-30.
23. Tolnay E, Wiethege T, Muller KM. Expression and localization of thrombomodulin in preneoplastic bronchial lesions and in lung cancer.Virchows Arch. 1997;430: 209-212.
24. Maruyama I, Majerus PW. The turnover of thrombin-thrombomodulin complex in cultured human umbilical vein endothelial cells and A549 lung cancer cells. Endocytosis and degradation of thrombin. J. Biol. Chem. 1985; 260: 15432-15438.
25. Smith BT. Cell line A549: a model system for the study of alveolar type II cell function. Am. Rev. Respir. Dis 1977;115: 285-293.
26. Mathews DH, Sabina J, Zuker M, Turner DH. Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure.J. Mol. Biol. 1999;288: 911-940.
27. Zuker M, Mathews DH, Turner DH. Algorithms and thermodynamics for RNA secondary structure prediction: A practical guide. In: Barciszewski J, Clark BFC, eds. RNA Biochemistry and Biotechnology. Dordrecht, The Netherlands: Kluwer Academic Publishers, 1999: 11-43.
28. Ciapetti G, Granchi D, Verri E, Savarino L, Cavedagna D, Pizzoferrato A. Application of a combination of neutral red and amido black staining for rapid, reliable cytotoxicity testing of biomaterials.Biomaterials 1996;17: 1259-1264.
29. Altschul SF, Madden TL, Schaffer AA et al. PSI-BLAST: a new generation of protein database search programs. Nucl. Acids Res. 1997;25: 3389-3402.
30. Grinnell BW, Berg DT. Surface thrombomodulin modulates thrombin receptor responses on vascular smooth muscle cells. Am. J. Physiol. 1996;270: H603-H609.
31. Li J, Garnette CS, Cahn M et al. Recombinant thrombomodulin inhibits arterial smooth muscle cell proliferation induced by thrombin.J. Vasc. Surg. 2000;32: 804-813.
32. Matsushita Y, Yoshiie K, Imamura Y et al. A subcloned human esophageal squamous cell carcinoma cell line with low thrombomodulin expression showed increased invasiveness compared with a high thrombomodulin-expressing clone -thrombomodulin as a possible candidate for an adhesion molecule of squamous cell carcinoma. Cancer Lett. 1998;127: 195-201.
33. Conway EM, Liu L, Nowakowski B, Steiner-Mosonyi M, Jackman RW. Heat shock of vascular endothelial cells induces an up-regulatory transcriptional response of the thrombomodulin gene that is delayed in onset and does not attenuate. J. Biol. Chem. 1994;269: 22804-22810.
34. Dittman WA, Nelson SC, Greer PK, Horton ET, Palomba ML, McCachren SS. Characterization of thrombomodulin expression in response to retinoic acid and identification of a retinoic acid response element in the human thrombomodulin gene.J. Biol. Chem. 1994;269: 16925-16932.
35. Moore KL, Andreoli SP, Esmon NL, Esmon CT, Bang NU. Endotoxin enhances tissue factor and suppresses thrombo-modulin expression of human vascular endothelium in vitro.J. Clin. Invest. 1987;79: 124-130.
36. Conway EM, Rosenberg RD. Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Mol. Cell Biol. 1988;8: 5588-5592.
37. Hirokawa K, Aoki N. Regulatory mechanisms for thrombomodulin expression in human umbilical vein endothelial cells in vitro. J. Cell Physiol. 1991;147: 157-165.
38. Ohji T, Urano H, Shirahata A et al. Transforming growth factor beta 1 and beta 2 induce down-modulation of thrombomodulin in human umbilical vein endothelial cells. Thromb. Haemost. 1995;73: 812-818.
39. Feuerstein N, Sahai A, Anderson WB, Salomon DS, Cooper HL. Differential phosphorylation events associated with phorbol ester effects on acceleration versus inhibition of cell growth. Cancer Res. 1984;44: 5227-5233.
40. Takehara K, LeRoy EC, Grotendorst GR. TGF-beta inhibition of endothelial cell proliferation: alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expression.Cell 1987;49: 415-422.
41. Olivot JM, Estebanell E, Lafay M, Brohard B, Aiach M, Rendu F. Thrombomodulin prolongs thrombin-induced extracellular signal-regulated kinase phosphorylation and nuclear retention in endothelial cells.Circ. Res. 2001;88: 681-687.
42. Assoian RK, Schwartz MA. Coordinate signaling by integrins and receptor tyrosine kinases in the regulation of G1 phase cell-cycle progression.Curr. Opin. Genet. Dev. 2001;11: 48-53.